InvestorQ : How does Cadila Healthcare look after the fall in profits in the Mar-20 quarter?
Katherine Gonsalves made post

How does Cadila Healthcare look after the fall in profits in the Mar-20 quarter?

Answer
user profile image
Rutuja Nigam answered.
3 months ago


Cadila Healthcare, one of the companies licensed by Gilead to manufacture Remdesivir in India, reported 14.8% percent fall in net profit at Rs.392 crore on a YOY basis. However, this cannot be taken as a comment on performance as this was more due to a one-time loss of Rs.52 crore booked in the quarter.

Cadila reported total sales revenues of Rs.3752 crore for the fourth quarter marginally higher than the number reported in the corresponding quarter last year. The operating profits were lower at Rs.791 crore but higher than estimates. Markets should construe these results positively in such trying conditions where supply chains were disrupted.